January 12, 2018Open Access

Role of TLR4 as a prognostic factor for survival in various cancers: a meta-analysis

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

The meta-analysis suggests that elevated expression of TLR4 is associated with poor OS and shorter DFS of patients with solid tumors. The results indicate that TLR4, as a novel prognostic biomarker in solid tumors, could potentially help to improve treatment decision-making of solid tumors in clinical.

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo

Cite This Study

Hao et al. (Fri,) studied this question.

synapsesocial.com/papers/69d84d1f8c03fbaff8beedf7 https://doi.org/https://doi.org/10.18632/oncotarget.24178

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1TLR signalling and activation of IRFs: revisiting old friends from the NF-κB pathway2005 · 341 citations
2Regulation of Snail transcription during epithelial to mesenchymal transition of tumor cells2004 · 336 citations
3Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses2010 · 17,733 citations
4Toll-Like Receptors2003 · 6,153 citations
5Global cancer statistics2011 · 55,054 citations

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo